Daniela Carvalho | Rahvusvaheline Huntingtoni Assotsiatsioon

Change your cover photo

Daniela Carvalho

This user account status is Approved

Comments Comments

UniQure announces alignment with FDA on key elements of accelerated approval pathway for AMT-130

1 päev ago in: News no comments

“The Present”, documentary featuring Dimitri Poffé, is now available on Youtube

3 päeva ago in: News no comments

PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington’s Disease Program

3 päeva ago in: News, Research no comments

Sage Therapeutics ceases development of dalzanemdor in HD

3 päeva ago in: News, Research no comments

Livable Lives – a new book that highlights stories from people impacted by HD around the world

1 kuu ago in: News, Stories no comments

LoQus23 Therapeutics announces £35 million financing to advance a new drug aimed at inhibiting somatic expansion in Huntington’s Disease

2 kuud ago in: News, Research no comments

FDA annab PTC518 Huntingtoni tõve programmile kiireloomulise nimetuse

3 kuud ago in: News 1 comment

Prilenia's Pridopidine's Huntingtoni tõve raviks on heaks kiidetud Euroopa müügiloa läbivaatamine

3 kuud ago in: News, Research no comments

Kibedate otsingute kroonika: The Making of a Foundation

4 kuud ago in: Stories no comments

IROS, Prilenia ja Rahvusvaheline Huntingtoni tõve ühing teevad koostööd esimese Huntingtoni tõve (HD) uuringu läbiviimiseks MENA piirkonnas.

5 kuud ago in: News no comments

load more posts

Estonian